• S. Korea Approves Novavax COVID-19 Vaccine
[Photo: AP-Newsis]  

South Korea's drug safety ministry has authorized the use of the two-dose coronavirus vaccine developed by U.S.-based biotechnology company Novavax.

The protein-based shot is the fifth to be approved for use in the country, following vaccines by AstraZeneca, Pfizer, Johnson & Johnson and Moderna.

It will be distributed by SK Bioscience, a unit of SK Group, and administered starting in the middle of February.

The ministry announced the decision Wednesday, saying Novavax's two-dose vaccine regimen will be administered 21 days apart in adults aged 18 and up.

It added the possibility of authorizing the vaccine for booster shots, pending further review.

Authorities, however, have yet to determine how effective the vaccine is against the more transmissible Omicron variant.

Please send comments to tbsefmnews@gmail.com / copyright © tbs. Unauthorized redistribution prohibited.

개인정보처리방침  l  영상정보처리기기방침  l  사이버 감사실  l  저작권 정책  l  광고 • 협찬단가표  l  시청자 위원회  l  정보공개

03909 서울특별시 마포구 매봉산로 31 S-PLEX CENTER | 문의전화 : 02-311-5114(ARS)
Copyright © Since 2020 Seoul Traffic Broadcasting. All Rights Reserved.